Congratulations to Dr. @MarlaLipsycMD (@DanaFarber ⭐️ senior co-fellow) on her incredible #ASCO22 oral presentation on “Circulating tumor DNA (ctDNA) and late recurrence in high-risk, hormone receptor–positive, HER2-negative breast cancer (CHiRP)”! Simultaneous @JCO_ASCO pub!
Congratulations to Dr. @MarlaLipsycMD (@DanaFarber ⭐️ senior co-fellow) on her incredible #ASCO22 oral presentation on “Circulating tumor DNA (ctDNA) and late recurrence in high-risk, hormone receptor–positive, HER2-negative breast cancer (CHiRP)”! Simultaneous @JCO_ASCO pub!
Tonight I will sleep easy for the first time in a long time. >500,000 single T cell transcriptomes, all publicly available. Also accepting donations after we spent all our money on this study. 🤣 Thank you so much @Nature! Have at it, world! 🍾🍾🍾
https://t.co/64rXOuKtw2
Was a pleasure to work on this review with @connors_md and @BTiu A comprehensive review of DOACs for cancer associated VTE prophylaxis or treatment #heme#oncology @BrighamHeme https://t.co/ZYQ4LN2yN4
#ASCO21 we are ready to go!💨
Here, some of the most interesting abstract on #LungCancer#LCSM that will be presented, very soon!
Take a look at that & enjoy 👁🗨
In response to a recent @nytimes investigation, we have updated our position statement on #sicklecell trait and will focus on education and training to end this injustice. Read more: https://t.co/NyznrAQxig
Please consider donating whatever you can in Francisco’s honor. Thank you. My Giving Page: Francisco Marty, MD, Legacy Lecture's Fundraising Page - My Fundraising Page https://t.co/NfGJolJ6kD